Advanced Energy

AEIS
Financial Analysis · Updated June 10, 2026 · Coverage 2026-Q2

Business Overview


source: coverage-next-full step: 01 ticker: AEIS company: Advanced Energy Industries, Inc. date: 2026-06-08

Step 01 — Business Model Overview: AEIS

S1 Business Description

Advanced Energy Industries (AEIS) is a precision power electronics company. It designs, manufactures, and services highly engineered power conversion, measurement, and control systems that transform raw utility power into the precise, controllable power required by semiconductor fabrication equipment, data center servers, medical devices, industrial machinery, and telecommunications gear. [S1: 10-K FY2025]

AEIS does not make the end equipment — it makes the critical enabling sub-system within it. A semiconductor etch tool at Applied Materials or Lam Research cannot function without AEIS's RF generators and plasma matching networks. A modern AI server rack at a hyperscaler needs AEIS's 48V rack power supplies to efficiently deliver clean power to GPUs and CPUs. This "inside the machine" positioning creates deep customer stickiness via long OEM qualification cycles and recipe lock-in.


S2 Value-Chain Layer Map

Layer 5: End Customers
  (Chip fabs: TSMC, Samsung, Intel | Hyperscalers: Meta, Microsoft, etc. | Industrial/Med OEMs)

Layer 4: Equipment/System OEMs
  (Applied Materials, Lam Research, ASML, Vertiv | Server OEMs)

Layer 3: AEIS — Critical Power Sub-Systems ← AEIS competes here
  Products: RF generators, plasma matching networks, HV power, rack power supplies,
            sensing & control, embedded power

Layer 2: Component suppliers
  (Semiconductors, capacitors, magnetics, cooling)

Layer 1: Raw materials / fabrication
  (PCB, metal, specialty components)

AEIS occupies Layer 3 — a sole-source or dual-source position inside OEM equipment. [S2: 10-K + industry research]


S3 Revenue Model

Product revenue (89.8% of FY2025): Precision power systems sold primarily through direct sales to semiconductor equipment OEMs, hyperscalers (data center), and industrial/medical OEMs. Products are typically capital goods with multi-year lifecycle.

Services revenue (10.2% of FY2025 = $183.9M): Repair, maintenance, calibration, conversion, and upgrade services on installed power products. Recurring, moderately sticky — tied to installed base utilization rates in semiconductor fabs.

Pricing model: Custom-engineered products priced per design win (not commodity pricing). ASPs range from hundreds of dollars (small embedded supplies) to tens of thousands (high-power RF systems). Data center power supplies trend toward higher ASPs as rack architectures migrate from 12V to 48V and 800V. [S3: 10-K FY2025 + investor presentation research]


S4 Customer Concentration

Three customers each exceeded 10% of FY2025 total revenue:

  • Customer A (est. ~23%): Likely Applied Materials (was named at 22-26% historically) [A05]
  • Customer B (est. ~19%): Likely a major hyperscaler (data center segment doubled) [A05]
  • Customer C (est. ~12%): Likely Lam Research (was named at 11% in FY2024) [A05]

Combined top-3 customers ≈ 54% of FY2025 revenue. High concentration risk — loss of any top customer would materially impair results. [S1: 10-K FY2025]

Historical named customers (FY2024 10-K): Applied Materials 26%, Lam Research 11%.


S5 Geographic Footprint

Revenue by destination (FY2025): US $541.4M (30.1%), Mexico $252.8M (14.1%), Japan $218.2M (12.1%), Taiwan $130.2M (7.2%), other $656.2M (36.5%).

Japan surge ($53.6M FY2024 → $218.2M FY2025) likely reflects new AI data center customer wins or semiconductor fab wins (Rapidus, Sony). Mexico strong at $252.8M (up from $160.1M) — reflects data center infrastructure or OEM manufacturing presence. [S1: 10-K FY2025]

Manufacturing footprint:

  • Asia PP&E $146.4M (largest; includes China closure underway, Vietnam, Malaysia)
  • US PP&E $107.6M
  • Europe/other $18.8M
  • Thailand factory: Under construction, $1B+ capacity target, opening Q4 2026 — major CapEx driver [S4: investor presentation]

S6 Competitive Positioning Summary

AEIS competes in three distinct markets with different dynamics:

Segment Primary Competitors AEIS Position
Semiconductor power (RF/HV) MKS Instruments, Comet Group Co-leader (MKS larger overall)
Data center rack power Bel Fuse, Flex, Murata, Vicor Scale player, growing fast
Industrial/Medical power Vicor, Bel Fuse, Acuity (ABB), Ametek Mid-tier

S7 Key Business Model Strengths

  1. Design-win moat: Semiconductor OEM qualification cycles are 12–24 months; once inside a tool design, revenue follows for the 10+ year tool production run. Switching costs are extremely high. [S2]
  2. Multi-market revenue diversification: Offsetting cyclicality — when semiconductor equipment downcycles, data center and medical provide ballast (demonstrated in FY2024 trough). [S1]
  3. Service revenue base ($183.9M): Recurring revenue tied to installed base, providing downside revenue floor. [S1]
  4. AI infrastructure secular tailwind: Data center power is a new $1B+ revenue vector with structural multi-year demand driven by GPU compute density and rack power density requirements. [S3]

S8 Key Business Model Risks

  1. Customer concentration: ~54% revenue in 3 customers; ~80%+ of semiconductor segment in 2 OEMs.
  2. WFE cyclicality: Semiconductor equipment market is highly cyclical (-11% to +60% swings); FY2024 trough demonstrated the exposure.
  3. Data center demand lumpiness: AI capex is driven by hyperscaler buildout cycles — could prove episodic rather than secular.
  4. Manufacturing transition risk: Thailand factory + China closure create execution risk through 2027.
  5. Convertible note overhang: $575M converts due 2028; dilution or refinancing risk.

Source Index

ID Source Date
S1 AEIS 10-K FY2025 2026-06-08
S2 Industry competitive landscape research 2026-06-08
S3 AEIS investor presentation (June 2026) + IR materials 2026-06-08
S4 AEIS 10-K FY2024 2026-06-08

Financial Snapshot


source: coverage-next-full step: 04 ticker: AEIS company: Advanced Energy Industries, Inc. date: 2026-06-08

Step 04 — Financial Quality & Adversarial Sweep: AEIS

S1 Financial Statement Quality Assessment

Quality Flags and Adjustments

1. Non-GAAP vs. GAAP divergence (significant) AEIS's FY2025 GAAP diluted EPS was $3.84, while non-GAAP EPS was approximately $7.30 (estimated from Q1–Q4 non-GAAP quarters). This ~$3.46/share gap ($130M+) represents:

  • SBC ($55.7M in FY2025) — large relative to net income
  • Intangible amortization from acquisitions ($22.1M)
  • Restructuring charges ($12.5M)
  • Acquisition-related expenses and other

[Fact] SBC as % of revenue: 3.1% (FY2025), up from ~2.7% (FY2024). Growing in absolute terms. [S1: 10-K FY2025]

[Judgment] The non-GAAP adjustments are relatively standard for a company that has completed multiple acquisitions. Intangible amortization and one-time restructuring are legitimately non-recurring. SBC is real dilution cost — we treat this as real expense in analytical work.

2. Customer concentration creates revenue visibility risk Three customers = ~54% of revenue. Revenue recognition is primarily on shipment/delivery. No backlog disclosed. Orders placed on purchase order basis, cancellable without penalty. This means forward revenue is less visible than subscription-model businesses. [S1]

3. Effective tax rate variability

  • FY2025 effective tax rate: ~11.5% (tax provision $19.4M on $168.7M pre-tax income)
  • FY2024: negative tax rate (tax benefit vs. low pre-tax income)
  • Low effective rate in FY2025 likely driven by R&D tax credits, geographic tax mix (Asia manufacturing), and equity compensation deductions
  • Risk: Higher normalized effective tax rate (20–25%) would reduce EPS by ~$1.00–2.00/share vs. management guidance

4. CapEx step-up requires monitoring FY2025 CapEx of $107.4M vs. $56.8M in FY2024 — nearly 2x increase. This reflects Thailand factory construction (opening Q4 2026). FCF yield compresses materially during this period. Post-construction, CapEx should normalize. [S2]

5. Convertible notes ($575M, 2.50%, due Sep 2028) Convertible at $116.25/share (roughly; conversion premium vs. issuance price). At current price of $307.16, these are deeply in-the-money. Conversion would be dilutive by ~4.9M shares (~13% dilution to current share count). AEIS has a call spread overlay (bought calls, sold warrants) that partially hedges dilution up to certain price levels. Full dilution EPS impact needs monitoring as the 2028 maturity approaches. [S1]


S2 Earnings Quality Metrics

Metric FY2023 FY2024 FY2025 Assessment
Operating CF / Net Income 1.63x 2.32x 1.56x Good — OCF consistently above net income
FCF / Net Income 1.15x 1.31x 0.84x FY2025 compressed by CapEx build
Accruals ratio Low Low Low Clean
Gross margin stability 35.7–36.6% 35.7% 37.7% Stable with expansion trend
Revenue recognition method Point-in-time (product) + ratable (service) Clean Clean Standard; no aggressive recognition

[S2: StockAnalysis + 10-K]

Earnings Quality: GOOD. Operating cash flow consistently exceeds net income (1.5x–2.3x in 3 years), indicating real earnings. Revenue recognition is straightforward. No red flags on receivables build or inventory pileup.


S3 Balance Sheet Quality

Goodwill and intangibles:

  • Total assets $2,546M; goodwill and intangibles are significant given Artesyn ($400M, 2019), SL Power ($68M, 2022), and Airity (2024) acquisitions.
  • Goodwill impairment risk: AEIS passed impairment tests but Industrial/Medical segment underperformance bears watching.

Working capital:

  • Receivables and inventory levels not explicitly available in this dataset; industrial companies typically run 60–90 days receivable; AEIS's large OEM customers may have extended payment terms.

Pension obligations:

  • AEIS maintains defined benefit pension plans (flagged in 10-K risk factors). Unfunded status and interest rate sensitivity are non-trivial risks.

Net cash position is genuine: $791.2M cash vs. $679M debt = ~$112M net cash at FY2025 year-end. This is after a significant debt reduction — $575M converts + smaller term loan replaced $1B+ gross debt of FY2023. [S2]


S4 Adversarial Research Sweep

This section reviews short seller reports, regulatory investigations, legal proceedings, and negative press to surface tail risks not visible in financial statements. Note: earnings transcripts not available (coverage-next-full path). Information sourced from filings, press releases, and public news.

Short Seller / Bear Reports

No active well-known short seller reports found on AEIS. Stock has short interest but no prominent thesis published in public research databases accessible via search. [S3: web search]

Legal Proceedings (from 10-K FY2025)

Material litigation not highlighted. AEIS includes standard "various legal proceedings in the ordinary course of business" language without indicating material pending litigation. No class action securities fraud suits, environmental liability, or product liability claims of note disclosed in FY2025 10-K. [S1]

Regulatory / Export Control Risk
  • U.S. export controls on semiconductor equipment to China are a risk — AEIS's semiconductor products may be subject to BIS licensing requirements. China revenue was <6% of FY2024; AEIS closed its Zhongshan, China manufacturing facility in 2025, reducing operational exposure but not eliminating customer exposure.
  • Tariff impact: Mentioned in 10-K as potentially material in future periods (was not material in FY2025). Supply chain reconfiguration to Thailand partially addresses this.
Customer Dependence Concentration Risk
  • Applied Materials (~23%) and Lam Research (~12%) are both subject to their own cyclical pressures and WFE cycle timing. If either reduces capex or inventory significantly, AEIS faces near-term revenue headwind.
  • One unnamed hyperscaler (~19%) represents a significant and concentrated data center revenue relationship with limited visibility disclosed. Customer not named; concentration in Japan revenue spike suggests a specific customer relationship.
Management / Governance Flags
  • CEO pay ratio of 840:1 is elevated but not uncommon for global manufacturing companies.
  • Incentive plan expansion in May 2026 received only 76.7% shareholder approval — below typical 90%+ threshold; indicates some institutional shareholder pushback on dilution.
  • Authorized share count doubled (70M→140M) at May 2026 meeting — provides M&A flexibility but creates dilution optionality that shareholders may not welcome.
  • All recent insider transactions (CEO, CFO, directors) have been 10b5-1 plan sales following the 190% stock run. Net sellers post large appreciation — ordinary diversification, not a red flag.
Manufacturing Transition Risk
  • China factory closure + Thailand factory (Q4 2026 opening) creates a 12–18 month window of manufacturing risk (customer disruption, quality issues, cost overruns). Not unique to AEIS but a real near-term operational risk. [S1]
Historical Investigations

No SEC enforcement actions, material restatements, or accounting fraud allegations found in public records. [S3: web search]


S5 Financial Quality Summary

Dimension Rating Key Note
Earnings quality (cash conversion) A OCF > net income consistently
Revenue quality (recognition) A Standard hardware recognition, no aggressive policies
Balance sheet (net cash, leverage) A- Net cash positive; convertible note 2028 maturity is a watch
Governance B+ Say-on-pay 98.7% but incentive plan 76.7%; elevated CEO pay
Litigation / regulatory B+ No material suits; export control risk real but managed
Accounting complexity B Non-GAAP/GAAP $3.46 EPS gap; SBC dilution real

Overall Financial Quality: GOOD — B+


Source Index

ID Source Date
S1 AEIS 10-K FY2025 (legal proceedings, risk factors, debt structure) 2026-06-08
S2 StockAnalysis.com financials + XBRL data 2026-06-08
S3 Web search: AEIS short reports, legal proceedings, SEC enforcement 2026-06-08
S4 AEIS proxy DEF 14A (May 2026) 2026-06-08

Deeper Financial Analysis

The fundamental tier adds 9 additional research dimensions for $AEIS.

Revenue Breakdown
Segment revenue, geographic mix, product-line contribution margins, and cohort dynamics.
Financial Trends
Quarter-over-quarter momentum, leading indicators, and inflection point analysis.
Balance Sheet
Debt structure, liquidity runway, dilution risk, and working capital dynamics.
Capital Allocation
Buyback cadence, M&A appetite, dividend policy, and reinvestment priorities.
Returns on Capital (ROIC)
Multi-year ROIC vs. WACC, marginal returns on reinvestment, sales-to-invested-capital efficiency, and moat spread.
GET /api/v1/research/AEIS/fundamental$1.00 · Bearer token required
Markdown: /stocks/aeis/financials/md · → thesis · → memo